|
1
|
European Association for the Study of the
Liver. Electronic address, . simpleeasloffice@easloffice.eu;
European Association for the Study of the Liver: EASL clinical
practice guidelines: Management of hepatocellular carcinoma. J
Hepatol. 69:182–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nowak AK, Chow PK and Findlay M: Systemic
therapy for advanced hepatocellular carcinoma: A review. Eur J
Cancer. 40:1474–1484. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qin S, Bai Y, Lim HY, Thongprasert S, Chao
Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, et al:
Randomized, multicenter, open-label study of oxaliplatin plus
fluorouracil/leucovorin versus doxorubicin as palliative
chemotherapy in patients with advanced hepatocellular carcinoma
from Asia. J Clin Oncol. 31:3501–3508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J, Duan B, Guo Y, Zhou R, Sun J, Bie B,
Yang S, Huang C, Yang J and Li Z: Baicalein sensitizes
hepatocellular carcinoma cells to 5-FU and epirubicin by activating
apoptosis and ameliorating P-glycoprotein activity. Biomed
Pharmacother. 98:806–812. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee TK, Castilho A, Cheung VC, Tang KH, Ma
S and Ng IO: CD24(+) liver tumor-initiating cells drive
self-renewal and tumor initiation through STAT3-mediated NANOG
regulation. Cell Stem Cell. 9:50–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roos WP, Thomas AD and Kaina B: DNA damage
and the balance between survival and death in cancer biology. Nat
Rev Cancer. 16:20–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lo SJ, Fan LC, Tsai YF, Lin KY, Huang HL,
Wang TH, Liu H, Chen TC, Huang SF, Chang CJ, et al: A novel
interaction of nucleophosmin with BCL2-associated X protein
regulating death evasion and drug sensitivity in human hepatoma
cells. Hepatology. 57:1893–1905. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ding ZB, Hui B, Shi YH, Zhou J, Peng YF,
Gu CY, Yang H, Shi GM, Ke AW, Wang XY, et al: Autophagy activation
in hepatocellular carcinoma contributes to the tolerance of
oxaliplatin via reactive oxygen species modulation. Clin Cancer
Res. 17:6229–6238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ashrafi G and Schwarz TL: The pathways of
mitophagy for quality control and clearance of mitochondria. Cell
Death Differ. 20:31–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vives-Bauza C, Zhou C, Huang Y, Cui M, de
Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, et al:
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.
Proc Natl Acad Sci USA. 107:378–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Youle RJ and Narendra DP: Mechanisms of
mitophagy. Nat Rev Mol Cell Biol. 12:9–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eisner V, Picard M and Hajnóczky G:
Mitochondrial dynamics in adaptive and maladaptive cellular stress
responses. Nat Cell Biol. 20:755–765. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roy M, Reddy PH, Iijima M and Sesaki H:
Mitochondrial division and fusion in metabolism. Curr Opin Cell
Biol. 33:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang EF, Palikaras K, Sun N, Fivenson EM,
Spangler RD, Kerr JS, Cordonnier SA, Hou Y, Dombi E, Kassahun H, et
al: In vitro and in vivo detection of mitophagy in human cells,
C. elegans, and mice. J Vis Exp. 22:2017.
|
|
15
|
Shimizu S and Tsujimoto Y: Proapoptotic
BH3-only Bcl-2 family members induce cytochrome c release,
but not mitochondrial membrane potential loss, and do not directly
modulate voltage-dependent anion channel activity. Proc Natl Acad
Sci USA. 97:577–582. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shimizu S, Narita M and Tsujimoto Y and
Tsujimoto Y: Bcl-2 family proteins regulate the release of
apoptogenic cytochrome c by the mitochondrial channel VDAC.
Nature. 399:483–487. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vander Heiden MG, Chandel NS, Williamson
EK, Schumacker PT and Thompson CB: Bcl-xL regulates the membrane
potential and volume homeostasis of mitochondria. Cell. 91:627–637.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kubli DA and Gustafsson AB: Mitochondria
and mitophagy: The yin and yang of cell death control. Circ Res.
111:1208–1221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou H, Zhu P, Guo J, Hu N, Wang S, Li D,
Hu S, Ren J, Cao F and Chen Y: Ripk3 induces mitochondrial
apoptosis via inhibition of FUNDC1 mitophagy in cardiac IR injury.
Redox Biol. 13:498–507. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Debatin KM, Poncet D and Kroemer G:
Chemotherapy: Targeting the mitochondrial cell death pathway.
Oncogene. 21:8786–8803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Graef M: A dividing matter:
Drp1/Dnm1-independent mitophagy. J Cell Biol. 215:599–601. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lima AR, Santos L, Correia M, Soares P,
Sobrinho-Simões M, Melo M and Máximo V: Dynamin-related protein 1
at the crossroads of cancer. Genes (Basel). 9:E1152018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Galluzzi L, Vitale I, Michels J, Brenner
C, Szabadkai G, Harel-Bellan A, Castedo M and Kroemer G: Systems
biology of cisplatin resistance: Past, present and future. Cell
Death Dis. 5:e12572014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marullo R, Werner E, Degtyareva N, Moore
B, Altavilla G, Ramalingam SS and Doetsch PW: Cisplatin induces a
mitochondrial-ROS response that contributes to cytotoxicity
depending on mitochondrial redox status and bioenergetic functions.
PLoS One. 8:e811622013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cassidy-Stone A, Chipuk JE, Ingerman E,
Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR
and Nunnari J: Chemical inhibition of the mitochondrial division
dynamin reveals its role in Bax/Bak-dependent mitochondrial outer
membrane permeabilization. Dev Cell. 14:193–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Alavian KN, Lazrove E, Mehta N,
Jones A, Zhang P, Licznerski P, Graham M, Uo T, Guo J, et al: A
Bcl-xL-Drp1 complex regulates synaptic vesicle membrane dynamics
during endocytosis. Nat Cell Biol. 15:773–785. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Chen Y, Jones AF, Sanger RH, Collis
LP, Flannery R, McNay EC, Yu T, Schwarzenbacher R, Bossy B, et al:
Bcl-xL induces Drp1-dependent synapse formation in cultured
hippocampal neurons. Proc Natl Acad Sci USA. 105:2169–2174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bordt EA, Clerc P, Roelofs BA, Saladino
AJ, Tretter L, Adam-Vizi V, Cherok E, Khalil A, Yadava N, Ge SX, et
al: The putative Drp1 inhibitor mdivi-1 is a reversible
mitochondrial complex I inhibitor that modulates reactive oxygen
species. Dev Cell. 40:583–594.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
